Harmony Capital Stock vs Net Working Capital Analysis

HRMY Stock

USD 29.32 0.39 1.35%

Harmony Biosciences financial indicator trend analysis is much more than just examining Harmony Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Harmony Biosciences is a good investment. Please check the relationship between Harmony Biosciences Capital Stock and its Net Working Capital accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Capital Stock vs Net Working Capital

Capital Stock vs Net Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Harmony Biosciences Capital Stock account and Net Working Capital. At this time, the significance of the direction appears to have pay attention.

The correlation between Harmony Biosciences' Capital Stock and Net Working Capital is -0.89. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Harmony Biosciences Holdings, assuming nothing else is changed. The correlation between historical values of Harmony Biosciences' Capital Stock and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Harmony Biosciences Holdings are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Capital Stock i.e., Harmony Biosciences' Capital Stock and Net Working Capital go up and down completely randomly.

Correlation Coefficient

-0.89

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Capital Stock

The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.

Net Working Capital

Most indicators from Harmony Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Harmony Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At this time, Harmony Biosciences' Tax Provision is fairly stable compared to the past year. Enterprise Value is likely to rise to about 1.8 B in 2024, whereas Selling General Administrative is likely to drop slightly above 60.8 M in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	18.8M	23.4M	24.3M	14.7M
Total Operating Expenses	162.4M	234.2M	268.8M	178.2M

Reconciled Depreciation Total Operating Expenses

Harmony Biosciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital
Total Assets		0.41	0.91	0.87	0.73	0.91	-0.95	-0.12	0.02	0.66	0.96	0.99	0.88	0.83	0.98	0.74	0.89	0.73	0.82	0.93	0.95	-0.94	0.99	-0.92	0.86	0.94
Other Current Liab	0.41		0.56	0.11	0.13	0.26	-0.34	0.28	-0.53	-0.05	0.44	0.4	-0.03	0.11	0.44	0.31	0.55	0.16	0.44	0.57	0.38	-0.51	0.41	-0.5	0.21	0.28
Total Current Liabilities	0.91	0.56		0.72	0.59	0.78	-0.87	-0.07	-0.1	0.67	0.91	0.92	0.73	0.69	0.89	0.69	0.86	0.45	0.72	0.94	0.87	-0.91	0.89	-0.87	0.66	0.74
Total Stockholder Equity	0.87	0.11	0.72		0.59	0.96	-0.9	-0.41	0.42	0.8	0.82	0.85	0.82	0.97	0.87	0.64	0.67	0.8	0.73	0.71	0.92	-0.74	0.87	-0.8	0.74	0.88
Other Liab	0.73	0.13	0.59	0.59		0.71	-0.75	-0.01	-0.28	0.33	0.8	0.69	0.78	0.45	0.76	0.61	0.8	0.46	0.77	0.74	0.78	-0.81	0.76	-0.82	0.96	0.78
Net Tangible Assets	0.91	0.26	0.78	0.96	0.71		-0.91	-0.42	0.26	0.67	0.92	0.86	0.8	0.88	0.94	0.59	0.75	0.79	0.89	0.79	0.96	-0.81	0.94	-0.92	0.83	0.94
Property Plant And Equipment Net	-0.95	-0.34	-0.87	-0.9	-0.75	-0.91		0.06	0.0	-0.77	-0.9	-0.95	-0.85	-0.87	-0.92	-0.86	-0.92	-0.63	-0.75	-0.93	-0.98	0.95	-0.93	0.92	-0.85	-0.87
Net Debt	-0.12	0.28	-0.07	-0.41	-0.01	-0.42	0.06		-0.77	-0.21	-0.24	-0.01	-0.14	-0.3	-0.23	0.41	0.24	-0.35	-0.4	0.13	-0.19	-0.13	-0.2	0.16	-0.04	-0.26
Retained Earnings	0.02	-0.53	-0.1	0.42	-0.28	0.26	0.0	-0.77		0.41	-0.03	-0.01	0.15	0.45	0.03	-0.26	-0.38	0.38	-0.01	-0.28	0.04	0.28	0.04	0.14	-0.16	0.11
Accounts Payable	0.66	-0.05	0.67	0.8	0.33	0.67	-0.77	-0.21	0.41		0.56	0.71	0.71	0.86	0.57	0.69	0.54	0.34	0.3	0.61	0.7	-0.59	0.6	-0.53	0.41	0.5
Cash	0.96	0.44	0.91	0.82	0.8	0.92	-0.9	-0.24	-0.03	0.56		0.92	0.83	0.73	0.99	0.62	0.87	0.66	0.92	0.91	0.95	-0.92	0.98	-0.97	0.87	0.93
Non Current Assets Total	0.99	0.4	0.92	0.85	0.69	0.86	-0.95	-0.01	-0.01	0.71	0.92		0.89	0.84	0.95	0.8	0.9	0.68	0.73	0.94	0.93	-0.94	0.96	-0.87	0.81	0.89
Non Currrent Assets Other	0.88	-0.03	0.73	0.82	0.78	0.8	-0.85	-0.14	0.15	0.71	0.83	0.89		0.78	0.84	0.69	0.74	0.64	0.64	0.76	0.82	-0.8	0.86	-0.74	0.85	0.85
Other Assets	0.83	0.11	0.69	0.97	0.45	0.88	-0.87	-0.3	0.45	0.86	0.73	0.84	0.78		0.8	0.69	0.64	0.77	0.59	0.68	0.86	-0.69	0.81	-0.71	0.64	0.8
Cash And Short Term Investments	0.98	0.44	0.89	0.87	0.76	0.94	-0.92	-0.23	0.03	0.57	0.99	0.95	0.84	0.8		0.64	0.86	0.77	0.91	0.9	0.96	-0.91	1.0	-0.95	0.87	0.96
Common Stock Shares Outstanding	0.74	0.31	0.69	0.64	0.61	0.59	-0.86	0.41	-0.26	0.69	0.62	0.8	0.69	0.69	0.64		0.88	0.36	0.37	0.84	0.76	-0.86	0.67	-0.68	0.69	0.59
Non Current Liabilities Total	0.89	0.55	0.86	0.67	0.8	0.75	-0.92	0.24	-0.38	0.54	0.87	0.9	0.74	0.64	0.86	0.88		0.47	0.71	0.98	0.89	-0.99	0.87	-0.91	0.85	0.78
Other Current Assets	0.73	0.16	0.45	0.8	0.46	0.79	-0.63	-0.35	0.38	0.34	0.66	0.68	0.64	0.77	0.77	0.36	0.47		0.71	0.48	0.69	-0.52	0.77	-0.61	0.68	0.88
Other Stockholder Equity	0.82	0.44	0.72	0.73	0.77	0.89	-0.75	-0.4	-0.01	0.3	0.92	0.73	0.64	0.59	0.91	0.37	0.71	0.71		0.74	0.85	-0.76	0.89	-0.92	0.83	0.9
Total Liab	0.93	0.57	0.94	0.71	0.74	0.79	-0.93	0.13	-0.28	0.61	0.91	0.94	0.76	0.68	0.9	0.84	0.98	0.48	0.74		0.91	-0.99	0.9	-0.92	0.8	0.79
Net Invested Capital	0.95	0.38	0.87	0.92	0.78	0.96	-0.98	-0.19	0.04	0.7	0.95	0.93	0.82	0.86	0.96	0.76	0.89	0.69	0.85	0.91		-0.93	0.96	-0.97	0.88	0.92
Property Plant And Equipment Gross	-0.94	-0.51	-0.91	-0.74	-0.81	-0.81	0.95	-0.13	0.28	-0.59	-0.92	-0.94	-0.8	-0.69	-0.91	-0.86	-0.99	-0.52	-0.76	-0.99	-0.93		-0.92	0.94	-0.87	-0.83
Total Current Assets	0.99	0.41	0.89	0.87	0.76	0.94	-0.93	-0.2	0.04	0.6	0.98	0.96	0.86	0.81	1.0	0.67	0.87	0.77	0.89	0.9	0.96	-0.92		-0.94	0.88	0.96
Capital Stock	-0.92	-0.5	-0.87	-0.8	-0.82	-0.92	0.92	0.16	0.14	-0.53	-0.97	-0.87	-0.74	-0.71	-0.95	-0.68	-0.91	-0.61	-0.92	-0.92	-0.97	0.94	-0.94		-0.88	-0.89
Non Current Liabilities Other	0.86	0.21	0.66	0.74	0.96	0.83	-0.85	-0.04	-0.16	0.41	0.87	0.81	0.85	0.64	0.87	0.69	0.85	0.68	0.83	0.8	0.88	-0.87	0.88	-0.88		0.92
Net Working Capital	0.94	0.28	0.74	0.88	0.78	0.94	-0.87	-0.26	0.11	0.5	0.93	0.89	0.85	0.8	0.96	0.59	0.78	0.88	0.9	0.79	0.92	-0.83	0.96	-0.89	0.92

Click cells to compare fundamentals

Harmony Biosciences Account Relationship Matchups

Harmony Biosciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	106.7M	427.1M	433.4M	673.9M	811.4M	466.0M
Other Current Liab	13.5M	132.0M	1.4M	73.1M	7.8M	7.4M
Total Current Liabilities	19.9M	134.5M	53.8M	78.9M	163.8M	84.0M
Total Stockholder Equity	(11.6M)	97.2M	186.5M	402.8M	467.0M	490.3M
Other Liab	450K	1.1M	3.2M	1.5M	1.8M	1.5M
Net Tangible Assets	(495.0M)	(65.2M)	42.6M	241.9M	278.2M	292.1M
Property Plant And Equipment Net	1.3M	938K	820K	573K	371K	352.5K
Net Debt	73.5M	(34.4M)	(42.3M)	(52.1M)	(118.1M)	(112.2M)
Retained Earnings	(422.9M)	(488.2M)	(453.6M)	(272.1M)	(143.3M)	(150.4M)
Accounts Payable	6.4M	2.6M	1.0M	3.8M	17.7M	18.6M
Cash	24.5M	228.6M	234.3M	243.8M	311.7M	206.5M
Non Current Assets Total	75.2M	164.2M	149.0M	273.6M	360.4M	187.9M
Non Currrent Assets Other	1.7M	902K	4.3M	3.5M	6.6M	3.3M
Other Assets	1.7M	902K	4.3M	87.2M	100.3M	105.3M
Cash And Short Term Investments	24.5M	228.6M	234.3M	323.1M	353.5M	228.7M
Net Receivables	4.3M	22.2M	34.8M	54.7M	74.1M	77.8M
Common Stock Shares Outstanding	63.7M	56.9M	59.2M	61.1M	60.4M	64.3M
Liabilities And Stockholders Equity	106.7M	427.1M	433.4M	673.9M	811.4M	466.0M
Non Current Liabilities Total	98.4M	195.4M	193.2M	192.1M	180.7M	157.7M
Inventory	1.1M	3.8M	4.4M	4.3M	5.4M	3.5M
Other Current Assets	261K	1.3M	3.2M	8.8M	5.5M	4.0M
Other Stockholder Equity	1K	585.4M	640.1M	675.1M	610.3M	519.8M
Total Liab	118.3M	329.9M	246.9M	271.0M	344.5M	241.7M
Net Invested Capital	(324.9M)	291.4M	378.5M	594.5M	660.6M	693.6M
Total Current Assets	31.5M	262.9M	284.4M	400.3M	451.1M	278.1M
Non Current Liabilities Other	163K	893K	3.2M	2.5M	2.1M	1.7M
Net Working Capital	11.6M	128.4M	230.7M	321.4M	287.3M	194.1M
Property Plant Equipment	1.3M	938K	820K	573K	515.7K	837.9K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Harmony Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harmony Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harmony Biosciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harmony Biosciences Holdings Stock:

How To Invest In Harmony

Details

Is Harmony Stock a good investment?

Details

What is Harmony Biosciences' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Harmony Stock analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.

	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities

Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.43)

Earnings Share

2.13

Revenue Per Share

9.787

Quarterly Revenue Growth

0.313

Return On Assets

0.1616

The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harmony Capital Stock vs Net Working Capital Analysis

Capital Stock vs Net Working Capital

Capital Stock vs Net Working Capital Correlation Analysis

Correlation Coefficient

Capital Stock

Net Working Capital

Harmony Biosciences fundamental ratios Correlations

Harmony Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harmony Biosciences fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Harmony Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Assets Total	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Cash
Cash And Short Term Investments	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Cash

Property Plant And Equipment Gross	- 0.99	Total Liab
Property Plant And Equipment Gross	- 0.99	Non Current Liabilities Total
Net Invested Capital	- 0.98	Property Plant And Equipment Net
Capital Stock	- 0.97	Net Invested Capital
Capital Stock	- 0.97	Cash
Capital Stock	- 0.95	Cash And Short Term Investments